Atossa Genetics to Host 2014 Financial Results and Company Update Conference Call on Monday, March 30, 2015
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 03/26/15 -- (NASDAQ: ATOS) announced today that it will host a conference call on Monday, March 30, 2015 at 4:30 pm Eastern Time to review 2014 financial results and a company update. Following management''s formal remarks, there will be a question and answer session.
To listen to the call by phone, interested parties within the U.S. should call 1-866-652-5200 and International callers should call 1-412-317-6060. All callers should ask for the Atossa Genetics conference call. The conference call will also be available through a live webcast at . Details for the webcast may be found on the Company''s IR events page at .
A replay of the call will be available approximately one hour after the end of the call through April 30, 2015. The replay can be accessed via Atossa''s website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international) or Canada Toll Free at 855-669-9658. The replay conference ID number is 10062963.
Atossa Genetics Inc. is focused on improving breast health through the development of laboratory services, medical devices and therapeutics. The laboratory services are being developed by its subsidiary, The National Reference Laboratory for Breast Health, Inc. The laboratory services and the Company''s medical devices are being developed so they can be used as companions to therapeutics to treat various breast health conditions. For more information, please visit .
Forward-looking statements in this press release are subject to risks and uncertainties that may cause actual results to differ materially from the anticipated or estimated future results, including the risks and uncertainties associated with actions by the FDA, the outcome or timing of regulatory approvals needed by Atossa to sell its products, responses to regulatory matters, Atossa''s ability to achieve its objectives, continue to manufacture and sell its products, recalls of products, the safety and efficacy of Atossa''s products and services, performance of distributors, whether Atossa can launch and commercialize in the United States and foreign markets the additional tests, devices and therapeutics in its pipeline in a timely and cost effective manner, and other risks detailed from time to time in Atossa''s filings with the Securities and Exchange Commission, including without limitation its periodic reports on Form 10-K and 10-Q, each as amended and supplemented from time to time. Atossa does not undertake any obligation to update any forward looking statement.
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 26.03.2015 - 07:00 Uhr
Sprache: Deutsch
News-ID 1346911
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SEATTLE, WA
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 162 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Atossa Genetics to Host 2014 Financial Results and Company Update Conference Call on Monday, March 30, 2015
"
steht unter der journalistisch-redaktionellen Verantwortung von
Atossa Genetics, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
